Gary Rojewski has 29-years experience in the pharmaceutical industry. During that time he has worked for Procter & Gamble Pharmaceuticals, Warner Chilcott Pharmaceuticals and most recently Actavis. Throughout his pharmaceutical career he has been responsible for commercializing pharmaceutical products.
CEO – Gary Rojewski
LATEST ENZYME BIOSYSTEMS PRESS RELEASE & NEWS
EnzymeBioSystems (“ENZB”), a Nevada corporation, was founded on June 26, 2009, for the purpose of utilizing enzyme technologies to develop commercial solutions for a broad range of applications within the specialty chemical industry.
This application claims the benefit of United States Provisional Application No. 61/ — filed December –, 2011, the disclosure of which is incorporated herein by reference. This invention was made with government support under Grant No. 1R03- CA136014-01A2 awarded by the National Institutes of Health.